BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hwang TL, Lee LY, Wang CC, Liang Y, Huang SF, Wu CM. Claudin-4 expression is associated with tumor invasion, MMP-2 and MMP-9 expression in gastric cancer. Exp Ther Med. 2010;1:789-797. [PMID: 22993603 DOI: 10.3892/etm.2010.116] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang HL, Zhou PY, Zhang Y, Liu P. Relationships between abnormal MMP2 expression and prognosis in gastric cancer: a meta-analysis of cohort studies. Cancer Biother Radiopharm 2014;29:166-72. [PMID: 24784911 DOI: 10.1089/cbr.2014.1608] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
2 Yuan X, Liu K, Li Y, Zhang AZ, Wang XL, Jiang CH, Liang WH, Zhang HJ, Pang LJ, Li M, Yang L, Qi Y, Zheng Q, Li F, Hu JM. HPV16 infection promotes an M2 macrophage phenotype to promote the invasion and metastasis of esophageal squamous cell carcinoma. Clin Transl Oncol 2021. [PMID: 34075547 DOI: 10.1007/s12094-021-02642-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Popova OP, Kuznetsova AV, Bogomazova SY, Ivanov AA. Claudins as biomarkers of differential diagnosis and prognosis of tumors. J Cancer Res Clin Oncol 2021;147:2803-17. [PMID: 34241653 DOI: 10.1007/s00432-021-03725-0] [Reference Citation Analysis]
4 Tabariès S, Siegel PM. The role of claudins in cancer metastasis. Oncogene 2017;36:1176-90. [PMID: 27524421 DOI: 10.1038/onc.2016.289] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 11.2] [Reference Citation Analysis]
5 Sappayatosok K, Phattarataratip E. Overexpression of Claudin-1 is Associated with Advanced Clinical Stage and Invasive Pathologic Characteristics of Oral Squamous Cell Carcinoma. Head Neck Pathol 2015;9:173-80. [PMID: 25078758 DOI: 10.1007/s12105-014-0559-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
6 Song YX, Sun JX, Zhao JH, Yang YC, Shi JX, Wu ZH, Chen XW, Gao P, Miao ZF, Wang ZN. Non-coding RNAs participate in the regulatory network of CLDN4 via ceRNA mediated miRNA evasion. Nat Commun. 2017;8:289. [PMID: 28819095 DOI: 10.1038/s41467-017-00304-1] [Cited by in Crossref: 147] [Cited by in F6Publishing: 160] [Article Influence: 29.4] [Reference Citation Analysis]
7 Liu JX, Wei ZY, Chen JS, Lu HC, Hao L, Li WJ. Prognostic and clinical significance of claudin-4 in gastric cancer: a meta-analysis. World J Surg Oncol. 2015;13:207. [PMID: 26109060 DOI: 10.1186/s12957-015-0626-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
8 Jafari E, Safinejad S, Dabiri S, Naghibzadeh-Tahami A. Study of the Relationship between MMP-2 and MMP-9 and Her2/neu Overexpression in Gastric Cancer: Clinico- Pathological Correlations. Asian Pac J Cancer Prev 2021;22:811-7. [PMID: 33773545 DOI: 10.31557/APJCP.2021.22.3.811] [Reference Citation Analysis]
9 Ren XP, Zhang QA, Zheng Q. Effect of cyclopamine on expression of VEGF, MMP-2 and MMP-9 in gastric cancer cell line MKN45. Shijie Huaren Xiaohua Zazhi 2013; 21(16): 1527-1532 [DOI: 10.11569/wcjd.v21.i16.1527] [Reference Citation Analysis]
10 Gurgel DC, Valença-Junior JT, Dornelas CA, Vieira RB, Maia-Filho JT, Lima-Junior RC, Ribeiro RA, Almeida PR. Immunoexpression of metalloproteinases 2 and 14 and TIMP-2 inhibitor in main types of primary gastric carcinomas and lymph node metastasis. Pathol Oncol Res 2015;21:73-81. [PMID: 24800696 DOI: 10.1007/s12253-014-9790-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
11 Shen W, Xi H, Wei B, Chen L. The prognostic role of matrix metalloproteinase 2 in gastric cancer: a systematic review with meta-analysis. J Cancer Res Clin Oncol. 2014;140:1003-1009. [PMID: 24610446 DOI: 10.1007/s00432-014-1630-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
12 Abbaszadegan MR, Mojarrad M, Moghbeli M. Role of extra cellular proteins in gastric cancer progression and metastasis: an update. Genes Environ 2020;42:18. [PMID: 32467737 DOI: 10.1186/s41021-020-00157-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Chen X, Zhao J, Li A, Gao P, Sun J, Song Y, Liu J, Chen P, Wang Z. Clinicopathological significance of claudin 4 expression in gastric carcinoma: a systematic review and meta-analysis. Onco Targets Ther 2016;9:3205-12. [PMID: 27313466 DOI: 10.2147/OTT.S99461] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
14 Li S, Li Y, Tan B, An Z. Effect of KLF17 overexpression on epithelial-mesenchymal transition of gastric cancer cells. J Int Med Res 2021;49:3000605211051581. [PMID: 34738482 DOI: 10.1177/03000605211051581] [Reference Citation Analysis]
15 Hwang TL, Changchien TT, Wang CC, Wu CM. Claudin-4 expression in gastric cancer cells enhances the invasion and is associated with the increased level of matrix metalloproteinase-2 and -9 expression. Oncol Lett. 2014;8:1367-1371. [PMID: 25120725 DOI: 10.3892/ol.2014.2295] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
16 Luo J, Wang H, Chen H, Gan G, Zheng Y. CLDN4 silencing promotes proliferation and reduces chemotherapy sensitivity of gastric cancer cells through activation of the PI3K/Akt signalling pathway. Exp Physiol 2020;105:979-88. [PMID: 31856376 DOI: 10.1113/EP088112] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
17 Kozieł MJ, Ziaja M, Piastowska-Ciesielska AW. Intestinal Barrier, Claudins and Mycotoxins. Toxins (Basel) 2021;13:758. [PMID: 34822542 DOI: 10.3390/toxins13110758] [Reference Citation Analysis]
18 Xie R, Wang X, Qi G, Wu Z, Wei R, Li P, Zhang D. DDR1 enhances invasion and metastasis of gastric cancer via epithelial-mesenchymal transition. Tumour Biol 2016;37:12049-59. [PMID: 27179963 DOI: 10.1007/s13277-016-5070-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
19 Torres JB, Knight JC, Mosley MJ, Kersemans V, Koustoulidou S, Allen D, Kinchesh P, Smart S, Cornelissen B. Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody. Mol Imaging Biol 2018;20:292-9. [PMID: 28842811 DOI: 10.1007/s11307-017-1112-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
20 Isaacson KJ, Martin Jensen M, Subrahmanyam NB, Ghandehari H. Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression. J Control Release 2017;259:62-75. [PMID: 28153760 DOI: 10.1016/j.jconrel.2017.01.034] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 9.8] [Reference Citation Analysis]